Fibrinopeptide a plasma levels during low-estrogen oral contraceptive treatment
- 1 December 1984
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 30 (6) , 575-583
- https://doi.org/10.1016/0010-7824(84)90007-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Randomized Prospective Studies on Metabolic Effects of Oral ContraceptivesActa Obstetricia et Gynecologica Scandinavica, 1982
- At III content and antithrombin activity in oestrogen-progestogen and progestogen-only treated womenThrombosis Research, 1980
- Altered haemorheology in oral-contraceptive users.BMJ, 1980
- EFFECT OF ORAL CONTRACEPTIVES ON PLATELET NORADRENALINE AND 5-HYDROXYTRYPTAMINE RECEPTORS AND AGGREGATIONThe Lancet, 1979
- THE EFFECTS OF INTRAMUSCULAR NORETHISTERONE OENANTHATE USED AS A CONTRACEPTIVE ON INTRAVENOUS GLUCOSE TOLERANCE AND ON BLOOD COAGULATION FACTORS VII AND XBJOG: An International Journal of Obstetrics and Gynaecology, 1977
- Association between oral contraceptive use and thromboembolism: A new approach to its investigation based on plasma fibrinogen chromatographyAmerican Journal of Obstetrics and Gynecology, 1975
- Low Fibrinolytic Activity of Veins During Treatment with Ethinylo EstradiolPublished by Wiley ,1971
- THROMBOEMBOLISM AND ORAL CONTRACEPTIVERS: AN EPIDEMIOLOGIC CASE-CONTROL STUDY12American Journal of Epidemiology, 1969
- Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further ReportBMJ, 1969
- Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.BMJ, 1968